Generic competition has eroded sales of multiple sclerosis drug Ampyra, marketed as Fampyra outside the U.S. Biogen told Acorda Therapeutics that it’s terminating its ex-U.S. rights to Fampyra in order to focus on other priorities, which include expanding beyond MS.
UnitedHealth Group is leaving AHIP because it feels AHIP doesn't represent the company's and customers' best interests; a new breath test can help diagnose esophageal and gastric cancer in a matter of minutes.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Sanofi (NYSE:SNY) CEO Chris Viehbacher has definite thoughts about how to marry life science ideas with the financing that is the life blood for that innovation. The pharmaceutical giant earlier this year partnered with venture capital firm Third Rock Ventures to launch biotechnology company Warp Drive Bio. Supporting biotech company launches is not a typical […]
French pharmaceutical company Sanofi (NYSE: SNY) said it will shut down its Bridgewater, New Jersey-based research and development facilities and consolidate them in its Boston hub. The company said it could not say how many jobs would be cut when its Bridgewater r&d facilities shut in the fourth quarter of 2012. It will set up […]